化学発光免疫測定分析装置の市場規模、シェア、成長分析：製品別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

化学発光免疫測定分析装置の市場規模は2023年に59億米ドルで、2024年の62億6,000万米ドルから2032年には100億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは6.1％で成長する見通しです。

世界の化学発光市場は、感染症や慢性疾患の有病率の上昇に牽引され、著しい成長を遂げています。この市場は、健康関連マーカーの検出における高い感度と特異性により、診断ラボにとって極めて重要です。化学発光免疫測定分析装置は、がん、心疾患、感染症などの疾患の診断やモニタリングに重要な役割を果たしており、迅速で正確な診断ツールに対する根強い需要が浮き彫りになっています。医療費の増加、早期診断に対する意識の高まり、特に新興国でのヘルスケアインフラの進歩といった要因が市場開発を後押ししています。各社は性能を高めるために革新的な製品を積極的に投入しており、多様なヘルスケア施設のニーズに確実に応えています。主要な市場参入企業は、さまざまな容量や機能に合わせた多種多様な分析装置を提供し続けています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩

化学発光免疫測定分析装置市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 機器
• ソフトウェアとサービス
• 消耗品

化学発光免疫測定分析装置市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 感染症
• 腫瘍

化学発光免疫測定分析装置市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 製薬・バイオテクノロジー企業
• 臨床検査室

化学発光免疫測定分析装置市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Abbott Laboratories（USA）
• Siemens Healthineers AG（Germany）
• F. Hoffmann-La Roche Ltd（Switzerland）
• bioMerieux SA（France）
• DiaSorin S.p.A.（Italy）
• Ortho Clinical Diagnostics（USA）
• Snibe Diagnostic（China）
• Randox Laboratories Ltd.（UK）
• Tosoh Corporation（Japan）
• YHLO Biotech Co., Ltd.（China）
• Sysmex Corporation（Japan）
• Beckman Coulter, Inc.（USA）
• Autobio Diagnostics Co., Ltd.（China）
• Maccura Biotechnology Co., Ltd.（China）
• Luminex Corporation（USA）
• Fujirebio Holdings Inc.（Japan）
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（China）
• Bio-Rad Laboratories Inc.（USA）
• PerkinElmer（USA）
• Thermo Fisher Scientific Inc.（USA）

結論と提言

Chemiluminescence Immunoassay Analyzers Market size was valued at USD 5.9 billion in 2023 and is poised to grow from USD 6.26 billion in 2024 to USD 10.05 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

The global chemiluminescence market is witnessing significant growth, driven by the rising prevalence of infectious and chronic diseases. This market is crucial for diagnostic laboratories due to its high sensitivity and specificity in detecting health-related markers. Chemiluminescence immunoassay analyzers play a vital role in diagnosing and monitoring diseases like cancer, cardiac disorders, and infections, highlighting the persistent demand for rapid and accurate diagnostic tools. Factors such as increased healthcare spending, heightened awareness of early diagnosis, and advancements in healthcare infrastructure, particularly in developing nations, are propelling market expansion. Companies are actively launching innovative products to enhance performance, ensuring they meet the needs of diverse healthcare facilities. Major market players continue to offer a variety of analyzers tailored to different capacities and functions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Chemiluminescence Immunoassay Analyzers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Chemiluminescence Immunoassay Analyzers Market Segments Analysis

Global Chemiluminescence Immunoassay Analyzers Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Instruments, Software & Services and Consumables. Based on Application, the market is segmented into Infectious Diseases and Oncology. Based on End User, the market is segmented into Hospitals, Pharmaceutical & Biotech Firms and Clinical Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Chemiluminescence Immunoassay Analyzers Market

The rising incidence of infectious and chronic diseases has led to an increased demand for advanced diagnostic tools capable of providing accurate and timely results. Chemiluminescence immunoassay analyzers have emerged as essential instruments widely utilized in various diagnostic laboratories. The global emphasis on early disease detection and preventive healthcare further fuels the market growth for these analyzers. Continuous technological advancements play a crucial role in enhancing their performance, precision, and efficiency, making them indispensable in modern medical diagnostics. As healthcare providers seek reliable instruments to streamline diagnosis, the market for chemiluminescence immunoassay analyzers is poised for significant expansion.

Restraints in the Chemiluminescence Immunoassay Analyzers Market

A significant constraint within the Chemiluminescence Immunoassay Analyzers market is the considerable expense linked to both the procurement and upkeep of these advanced diagnostic technologies. The hefty initial financial commitment may restrict access for smaller healthcare facilities and laboratories, hindering their ability to adopt such innovative instruments. Additionally, the intricate nature of these analyzers, along with the complexities involved in interpreting their data, can create a learning curve for healthcare professionals, potentially delaying diagnostic processes. Furthermore, various regulatory challenges and compliance requirements across different regions can stall market growth, as stakeholders must navigate an array of standards and approval protocols.

Market Trends of the Chemiluminescence Immunoassay Analyzers Market

The Chemiluminescence Immunoassay Analyzers market is witnessing a significant trend towards the integration of automation and artificial intelligence (AI), enhancing laboratory efficiency and diagnostic accuracy. This technological advancement accelerates turnaround times and facilitates streamlined test administration, ultimately improving patient outcomes. The demand for these analyzers is expanding beyond traditional applications, with increasing interest in cancer diagnostics, microbial infection screenings, and hormone assessments. Additionally, manufacturers are focusing on designing user-friendly and portable analyzers to cater to the rising market for point-of-care (PoC) testing and remote diagnostics, positioning these devices as essential tools in modern healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Chemiluminescence Immunoassay Analyzers Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Software & Services
• Consumables

Global Chemiluminescence Immunoassay Analyzers Market Size by Application & CAGR (2025-2032)

• Market Overview
• Infectious Diseases
• Oncology

Global Chemiluminescence Immunoassay Analyzers Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Pharmaceutical & Biotech Firms
• Clinical Laboratories

Global Chemiluminescence Immunoassay Analyzers Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Snibe Diagnostic (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• YHLO Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autobio Diagnostics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Maccura Biotechnology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujirebio Holdings Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations